Helicobacter pylori Infection in Children: A Possible Reason for Headache?

Ancuta Lupu1, Cristina Gavrilovici1, Vasile Valeriu Lupu1

  • 1Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Insights

Helicobacter pylori (H. pylori) infection is significantly associated with headaches in children. This study highlights the importance of considering H. pylori in pediatric headache evaluations for prompt diagnosis and treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Neurology

Background:

  • The link between Helicobacter pylori (H. pylori) infection and headaches is debated, particularly in pediatric populations.
  • A clear association between H. pylori and headaches in children remains to be definitively established.
  • This study investigates the correlation in children from Northeast Romania.

Purpose of the Study:

  • To explore the relationship between H. pylori infection and the occurrence of headache or migraine in children.
  • To determine if H. pylori infection is a significant factor in pediatric headaches.

Main Methods:

  • A retrospective study design was employed.
  • Data from 1757 children hospitalized over 3 years in a pediatric gastroenterology department were analyzed.
  • The study focused on children with diagnosed H. pylori infection and those presenting with headache or migraine.

Main Results:

  • Out of 1757 children, 130 experienced headaches.
  • A significant correlation was found between H. pylori infection and headache in children (χ2; p < 0.01).
  • Approximately 41.5% (54 out of 130) of children with headaches were also infected with H. pylori.

Conclusions:

  • A significant association exists between H. pylori infection and headaches in the studied pediatric cohort.
  • Further research is warranted to fully understand this relationship.
  • Identifying H. pylori infection may be clinically important for the diagnosis and treatment of headaches in children.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
474
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
228
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
164
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
653
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
407
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
480